Sai Life Sciences has announced a board meeting scheduled for Thursday, November 6, 2025, to consider and approve the un-audited financial results for the quarter ended September 30, 2025. The trading window for company securities remains closed until November 8, 2025, for designated individuals.
Upcoming Board Meeting
The Board of Directors at Sai Life Sciences will convene on Thursday, November 6, 2025. The primary agenda is to review and approve the company’s un-audited financial results.
Financial Results on the Agenda
The board will specifically address the Standalone and Consolidated Financial Results for the fiscal quarter ending September 30, 2025. This assessment will provide insights into the company’s financial performance during Q2.
Trading Window Closure
In accordance with the company’s code of conduct for insider trading, the trading window for Sai Life Sciences’ securities has been closed since October 1, 2025. This restriction will remain in effect until November 8, 2025. The closure applies to directors, officials, and other designated individuals within the company to ensure compliance and prevent any potential misuse of confidential information.
Source: BSE
